An open clinical trial of benazepril--a new ACE inhibitor in mild-moderate hypertension. 1998

N D Karnik, and Y K Oza, and S P Sane, and R Kaushik, and A D Bhatt, and K P Chawla, and A B Vaidya, and V H Yajnik, and R C Khokhani
LTM Medical College and Hospital, Mumbai.

Benazepril hydrochloride, a new non-sulfhydryl ACE inhibitor (ACEI) was studied in a titrated dose of 10 mg-20 mg once a day for 6 weeks in 42 mild to moderate adult hypertensive patients with sitting diastolic blood pressure (SDBP) 95-114 mm Hg. The pre-drug SDBP(mean +/- SE) of 102.5 +/- 0.8 mm Hg showed a significant reduction to 87.5 +/- 0.93 mm Hg at the end of treatment. BP was controlled (SDBP < or = 90 mm Hg) in 34 (81%) patients and a drop of at least 10 mm Hg from the pre-treatment SDBP value was noted in 34 (81%) patients. Common adverse reaction was cough in 8(19%) patients. Clinically significant changes in laboratory evaluations were not seen in any patient. Study showed that benazepril in a dose range of 10 to 20 mg per day is an effective agent for treatment of mild to moderate hypertension.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000806 Angiotensin-Converting Enzyme Inhibitors A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility. ACE Inhibitor,ACE Inhibitors,Angiotensin Converting Enzyme Inhibitor,Angiotensin I-Converting Enzyme Inhibitor,Angiotensin-Converting Enzyme Inhibitor,Kininase II Inhibitor,Kininase II Inhibitors,Angiotensin I-Converting Enzyme Inhibitors,Angiotensin-Converting Enzyme Antagonists,Antagonists, Angiotensin-Converting Enzyme,Antagonists, Kininase II,Inhibitors, ACE,Inhibitors, Angiotensin-Converting Enzyme,Inhibitors, Kininase II,Kininase II Antagonists,Angiotensin Converting Enzyme Antagonists,Angiotensin Converting Enzyme Inhibitors,Angiotensin I Converting Enzyme Inhibitor,Angiotensin I Converting Enzyme Inhibitors,Antagonists, Angiotensin Converting Enzyme,Enzyme Antagonists, Angiotensin-Converting,Enzyme Inhibitor, Angiotensin-Converting,Enzyme Inhibitors, Angiotensin-Converting,II Inhibitor, Kininase,Inhibitor, ACE,Inhibitor, Angiotensin-Converting Enzyme,Inhibitor, Kininase II,Inhibitors, Angiotensin Converting Enzyme
D001552 Benzazepines Compounds with BENZENE fused to AZEPINES.

Related Publications

N D Karnik, and Y K Oza, and S P Sane, and R Kaushik, and A D Bhatt, and K P Chawla, and A B Vaidya, and V H Yajnik, and R C Khokhani
April 1993, ANNA journal,
N D Karnik, and Y K Oza, and S P Sane, and R Kaushik, and A D Bhatt, and K P Chawla, and A B Vaidya, and V H Yajnik, and R C Khokhani
March 1991, Clinical pharmacology and therapeutics,
N D Karnik, and Y K Oza, and S P Sane, and R Kaushik, and A D Bhatt, and K P Chawla, and A B Vaidya, and V H Yajnik, and R C Khokhani
June 1995, Cardiovascular drugs and therapy,
N D Karnik, and Y K Oza, and S P Sane, and R Kaushik, and A D Bhatt, and K P Chawla, and A B Vaidya, and V H Yajnik, and R C Khokhani
October 1991, Cardiologia (Rome, Italy),
N D Karnik, and Y K Oza, and S P Sane, and R Kaushik, and A D Bhatt, and K P Chawla, and A B Vaidya, and V H Yajnik, and R C Khokhani
August 1991, Clinical cardiology,
N D Karnik, and Y K Oza, and S P Sane, and R Kaushik, and A D Bhatt, and K P Chawla, and A B Vaidya, and V H Yajnik, and R C Khokhani
January 1997, West African journal of medicine,
N D Karnik, and Y K Oza, and S P Sane, and R Kaushik, and A D Bhatt, and K P Chawla, and A B Vaidya, and V H Yajnik, and R C Khokhani
February 1999, The Journal of the Association of Physicians of India,
N D Karnik, and Y K Oza, and S P Sane, and R Kaushik, and A D Bhatt, and K P Chawla, and A B Vaidya, and V H Yajnik, and R C Khokhani
July 1997, Orvosi hetilap,
N D Karnik, and Y K Oza, and S P Sane, and R Kaushik, and A D Bhatt, and K P Chawla, and A B Vaidya, and V H Yajnik, and R C Khokhani
March 1987, The New Zealand medical journal,
N D Karnik, and Y K Oza, and S P Sane, and R Kaushik, and A D Bhatt, and K P Chawla, and A B Vaidya, and V H Yajnik, and R C Khokhani
December 1998, Medizinische Klinik (Munich, Germany : 1983),
Copied contents to your clipboard!